The Recall Desk
Agency classClass IOur severity:SevereFDA (Food)·F-1300-2013·Announced 2013-04-17

Nutrex Research Recalls Lipo 6 Black Ultra Concentrate Due to DMAA

Nutrex Research is recalling Lipo 6 Black Ultra concentrate Fat Destroyer because samples contain DMAA (Methylhexanamine). The recall affects 82,417 sample packets distributed in eight states.

The agency’s classification

FDA (Food): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.

Plain-English summary

Nutrex Research, Inc. is recalling 82,417 sample packets of Lipo 6 Black Ultra concentrate Fat Destroyer. The product is identified by Lot # 50000114 and a best-by date of 01/2015. Each packet contains one capsule.

The recall is being conducted because product samples contain DMAA (Methylhexanamine). The affected product was distributed in Connecticut, Florida, Georgia, Illinois, Massachusetts, New Jersey, Nevada, and Texas.

Consumers who have this product should stop using it and return it to the place of purchase for a refund or contact the recalling firm for instructions.

The recalled product

Product
Nutrex Research Lipo 6 Black Ultra concentrate Fat Destroyer

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot # 50000114 Best by: 01/2015

Distribution

Distributed in 8 states:

Similar recalls